United Orthopedic (ROCO:4129) ROCE %: 14.06% (As of Dec. 2025)


ROCO:4129 United Orthopedic Corp ROCO:4129
81 GF Score
Price NT$92.90
GF Value NT$123.70
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is United Orthopedic ROCE %?

United Orthopedic ROCO:4129 +1.31% 81 ROCE % is 14.06% as of Dec. 2025. GuruFocus rates ROCO:4129 with a GF Score™ of 81/100 and a GF Value™ of NT$123.70 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. United Orthopedic's annualized ROCE % for the quarter that ended in Dec. 2025 was 14.06%.

United Orthopedic  (ROCO:4129) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

United Orthopedic ROCE % Related Terms

United Orthopedic ROCE % Historical Data

* Premium members only.

The historical data trend for United Orthopedic's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Orthopedic ROCE % Chart

United Orthopedic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.55 9.09 13.17 13.60 16.22

United Orthopedic Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.87 23.47 6.15 21.23 14.06
ROCO:4129
81GF Score
United Orthopedic Corp ROCO:4129
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Orthopedic ROCE % Calculation

United Orthopedic's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=802.349/( ( (7039.487 - 2470.798) + (7822.061 - 2499.939) )/ 2 )
=802.349/( (4568.689+5322.122)/ 2 )
=802.349/4945.4055
=16.22 %

United Orthopedic's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Sep. 2025 )(Q: Dec. 2025 )
=738.684/( ( (7462.63 - 2273.531) + (7822.061 - 2499.939) )/ 2 )
=738.684/( ( 5189.099 + 5322.122 )/ 2 )
=738.684/5255.6105
=14.06 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 14.06% mean?
United Orthopedic (ROCO:4129) has a ROCE % of 14.06% as of Dec. 2025.
Is United Orthopedic's ROCE % too high?
United Orthopedic's current ROCE % is 14.06%. The Medical Devices & Instruments industry median ROCE % is 2.20. United Orthopedic's value of 14.06% is 539.1% above this industry median. Overall, United Orthopedic has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does United Orthopedic's ROCE % compare to ABT and SYK?
United Orthopedic's ROCE % of 14.06% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. United Orthopedic's value of 14.06% is 539.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Orthopedic's current ROCE % of 14.06% is 539.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Orthopedic's current ROCE % is 14.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Orthopedic stock overvalued right now?
Based on GuruFocus' analysis, United Orthopedic (ROCO:4129) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$123.70, compared to a current price of NT$92.90 — trading 24.9% below its estimated fair value. The current ROCE % is 14.06% and 539.1% above the Medical Devices & Instruments industry median of 2.20. United Orthopedic's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For United Orthopedic (ROCO:4129), the current ROCE % is 14.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Orthopedic (ROCO:4129) Overvalued in 2026?

Based on GuruFocus' analysis, United Orthopedic stock appears to be undervalued. The current stock price of NT$92.90 is trading 24.9% below its estimated GF Value™ of NT$123.70. GuruFocus considers United Orthopedic to be Modestly Undervalued.

Key valuation signals for ROCO:4129:

  • ROCE %: 14.06%
  • GF Value™: NT$123.70 vs. price of NT$92.90 (24.9% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 539.1% above the Medical Devices & Instruments median

No single metric tells the full story. See the ROCO:4129 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Orthopedic Business Description

Address 12th Floor, No.80, Section 1, Chenggong Road, Yonghe District, New Taipei City, TWN, 234634
United Orthopedic Corp is engaged in the research, development, production, manufacturing, and sales of orthopedic implants, orthopedic surgical instruments and manufacturing equipment, special metal and plastics materials, as well as the import and export of the aforementioned products. Its products include Hip System, Knee System, and Limb Salvage.
81GF Score

Get the complete analysis for ROCO:4129

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$92.90
Price
NT$123.70
GF Value